Format

Send to

Choose Destination
Front Neurol. 2017 Jun 6;8:254. doi: 10.3389/fneur.2017.00254. eCollection 2017.

Fragile X Syndrome: Prevalence, Treatment, and Prevention in China.

Author information

1
Department of Pediatrics, Peking University First Hospital, Beijing, China.
2
MIND Institute, University of California-Davis Medical Center, Sacramento, CA, United States.
3
Ateneo de Manila University - School of Medicine and Public Health, Quezon, Philippines.
4
Department of Pediatrics, Peking University People's Hospital, Beijing, China.
5
Department of Pediatrics, University of California-Davis Medical Center, Sacramento, CA, United States.

Abstract

Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and the leading monogenic cause of autism spectrum disorder. Although FXS has been studied for several decades, there is relatively little basic science or clinical research being performed on FXS in China. Indeed, there is a large gap between China and Western countries in the FXS field. China has a potentially large number of FXS patients. However, many of them are underdiagnosed or even misdiagnosed, and treatments are not always administered in the Chinese population. This review discusses the prevalence, treatment, and prevention of FXS in China to facilitate an understanding of this disease in the Chinese population.

KEYWORDS:

China; fragile X syndrome; prevalence; prevention; treatment

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center